About us   Contacts   Links   Information in Russian 
Research programms
Publications

Abstracts 2010


1. Fedorenko D.A. Analiz rezul'tatov transplantacii autologichnyh gemopojeticheskih stvolovyh kletok u 180 bol'nyh rassejannym sklerozom / D.A. Fedorenko, T.I. Ionova, A.V. Kartashov, A.N. Kuznetsov, A.A. Novik // Stvolovye kletki i regenerativnaja medicina: sbornik tezisov Vserossijskoj nauchnoj shkoly-konferencii. - Мoscow, 2010. - P. 83–84. (in Russian)

2. Ionova T. New instrument for comprehensive symptom profile assessment in Hodgkin's lymphoma patients: applicability and characteristics IYtmatologica / T. Ionova, S. Kalyadina, D. Fedorenko, N. Mochkin, K. Kurbatova, T. Nikitina, G. Gorodokin, A. Novik // The Hematology Journal-8ths Intern Syposium on Hodgkin Lymphoma. Abstract book, 2010. P. 42.

3. Ionova T.I. Enhancing patient-physician communication by assessing cancer-related sympoms: discrepancies in estimation of symptom severity between a patient and a physician / T.I. Ionova, S.A. Kalyadina, A.A. Novik // Quality of life Research. 2010; 19: 7.

4. Kalyadina S.A. Applicability and characteristics of the new instrument for comprehensive symptom profile assessment in patients with malignant lymphomas / S.A. Kalyadina, D.A. Fedorenko, N.E. Mochkin, K.A. Kurbatova, T.P. Nikitina, G. Gorodokin, T.I. Ionova, A.A. Novik // Quality of life Research. 2010; 19: 53.

5. Novik A.A. PRO in decision making paradigm in clinical oncology: application to clinical practice / A.A. Novik, T.I. Ionova, G. Gorodokin // Quality of life Research. 2010; 19: 8.

6. Novik A. Comprehensive symptom profile for symptom assessment in patients with multiple sclerosis: applicability and characteristics / A. Novik, T. Ionova, S. Kalyadina, D. Fedorenko, N. Mochkin, K. Kurbatova, G. Gorodokin // Journal of Neurology. 2010; 257(1): 9.

7. Novik A.A. Comprehensive symptom profile (CSP-MS) for symptom assessment inpatients with multiple sclerosis (MS): applicability and characteristics / A.A. Novik, T.I. Ionova, S.A. Kalyadina, D.A. Fedorenko, N.E. Mochkin, K.A. Kurbatova, G. Gorodokin // European Journal of Neurology. 2010; 17(3): 224.

8. Novik A.A. New instrument for comprehensive symptom profile assessment in patients with malignant lymphomas / A.A. Novik, T.I. Ionova, S.A. Kalyadina, D.A. Fedorenko, N.E. Mochkin, K.A. Kurbatova, T.P. Nikitina, G.I. Gorodokin // Blood. 2010; 116: 2561.

9. Novik A. New instrument for comprehensive symptom profile assessment in patients with malignant lymphomas: applicability and characteristics / A. Novik, T. Ionova, S. Kalyadina, D. Fedorenko, N. Mochkin, K. Kurbatova, T. Nikitina, G. Gorodokin // Haemotologica. 2010; 95(2): 192.

10. Novik A.A. The utility of the new instrument for comprehensive symptom profile assessment in patients with multiple myeloma / A.A. Novik, T.I. Ionova, S.A. Kalyadina, D.A. Fedorenko, N.E. Mochkin, K.A. Kurbatova, T.P. Nikitina, G.I. Gorodokin // Blood. 2010; 116: 4757.

11. Novik A. Comprehensive symptom profile for symptom assessment in patients undergoing bone marrow transplantation / peripheral stem cell transplantation: applicability and characteristics. Bone Marrow Transplantation / A. Novik, T. Ionova, S. Kalyadina, D. Fedorenko, N. Mochkin, T. Nikitina, K. Kurbatova, G. Gorodokin // Abstract Book. 2010; 45(2): 112.

12. Novik A.A. Analysis of the outcomes of high-dose immunosuppressive therapy with autologous haematopoietic stem cell transplantation in 156 patients with multiple sclerosis / A.A. Novik, A.N. Kuznetsov, V.M. Kitaev, V.Y. Melnichenko, D.A. Fedorenko, T.I. Ionova, R.V. Kruglina, K.A. Kurbatova, G. Gorodokin* // Journal of Neurology. 2010; 257(1): 23.

13. Novik A.A. Reduced intensity conditioning regimen of autologous hematopoietic stem cell transplantation±mitoxantrone consolidation in multiple sclerosis / A.A. Novik, A.N. Kuznetsov, V.Y. Melnichenko, D.A. Fedorenko, A.V. Kartashov, T.I. Ionova, K.A. Kurbatova, G.I. Gorodokin // Blood. 2010; 116: 372.

14. Shevchenko Y. Advances in Multiple Sclerosis treatment: three strategies of high-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation / Y. Shevchenko, A. Novik, A. Kuznetsov, T. Ionova, V. Melnichenko, D. Fedorenko, A. Kartashov, R. Kruglina, K. Kurbatova, G. Gorodokin // 9 International Conference on New Trends in Immunosuppr & Immunotherapy. Abstract Book. 2010: 36.

15. Shevchenko Y.L. Autologous hematopoietic stem-celltransplantation (AHSCT) +/– consolidationtherapy in multiple sclerosis (MS) / Y.L. Shevchenko, A.A. Novik, A.N. Kuznetsov, V.Y. Melnichenko, D.A. Fedorenko, T.I. Ionova, A.V. Kartashov, K.A. Kurbatova, G. Gorodokin // European Journal of Neurology. 2010; 17(3): 30.

16. Shevchenko Y.L. Early vs conventional / late autologous hematopoietic stem cell transplantation in multiple sclerosis: lessons learned over the past ten years of Russian-American cooperation / Y.L. Shevchenko, A.A. Novik, A.N. Kuznetsov, V.Y. Melnichenko, D.A. Fedorenko, T.I. Ionova, A.V. Kartashov, K.A. Kurbatova, G. Gorodokin* // Haemotologica. 2010; 95(2): 211.

17. Shevchenko Y. New perspectives on the use of autologous hematopoietic stem cell transplantation in multiple sclerosis: three strategies of high-dose immunosuppressive therapy with autologous hematopoietic stem cell transplantation / Y. Shevchenko, A. Novik, A. Kuznetsov, V. Melnichenko, D. Fedorenko, T. Ionova, R. Kruglina, K. Kurbatova, A. Kartashov, G. Gorodokin // Bone Marrow Transplantation. Abstract Book. 2010; 45(2): 26.









© Создание сайтов

Последнее обновление (last update): 05-08-2020









Яндекс цитирования